Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes primary liver tumors originating in the liver, or metastasized tumors resulting from another cancer spreading to the liver. Histotripsy is a new option for patients with liver tumors who may not be a candidate for surgery or other traditional therapies.
Five Ochsner Health hospitals have been named among Newsweek’s America’s Best-in-State Hospitals 2026, recognizing their clinical excellence, patient experience and innovation. This honor highlights Ochsner’s commitment to top-quality care across Louisiana, Mississippi and the Gulf South.
Ochsner Baton Rouge welcomes several new physicians and advanced practice providers to Ochsner Medical Complex – The Grove.
Ochsner LSU Health clinics in Monroe will remain closed on Tuesday, Jan. 27, due to winter weather, while the Monroe Medical Center and emergency departments stay open. Virtual urgent care is available from 7 a.m. to 6:30 p.m.; visit ochsnerlsuhs.org/status for updates.
